Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Call to join the 2026 NHS Innovation Accelerator (NIA) program is now open in England

On September 1, 2025, the application window opened to join the 2026 NHS Innovation Accelerator (NIA) program. The application deadline is October 12, 2025.

NIA is funded by NHS England via the Accelerated Access Collaborative and delivered in partnership with all 15 Health Innovation Networks across England, hosted at UCLPartners. NIA supports the development of innovators (Fellows) and the spread of their innovation nationally.

The 2026 call for applications does not cover a specific theme and is open to innovations addressing any health and care challenges. However, NIA particularly welcomes innovations that address challenges highlighted by the NHS 10 Year Health Plan and Life Science Healthcare Goals (dementia, cancer, infrastructure around obesity, addiction, and mental health). Also, the NIA program particularly welcomes digital and AI-based innovations focused on women's health, and it would also love to see applications for more physical product innovations and medical devices.

Innovations addressing challenges listed by stakeholders as the most pressing should be prioritized for shortlisting. The examples include:

  • Remote clinical systems;
  • Digital tools in the areas of asthma, diabetes, and mental health;
  • Digital technologies for patients in the community with heart failure, high blood pressure, cardiac arrhythmia, or awaiting definitive cardiac interventions to guide treatment and signal any early signs of clinical deterioration;
  • Tests and platforms to support the diagnosis and management of sleep problems;
  • Digital health technologies to support people living with kidney disease;
  • AI and novel technologies in lung function measurement.

The final NIA Board decision on new NIA Fellows to join the program is scheduled for February 2026.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.